Improve the way you reach your nutrition goals with Encala
If you or someone you love suffers from fat malabsorption associated with exocrine pancreatic insufficiency (EPI), you’ll want to know about Encala.
Encala helps people with cystic fibrosis (CF) and exocrine pancreatic insufficiency (EPI) get the nutrition they need to improve their weight, height, and body mass index (BMI) in a healthy way, simply by adding it to foods and beverages they already eat.
Encala is the first medical food formulated specifically to help people with CF and EPI absorb more healthy fat, calories, and nutrients
People with fat malabsorption sometimes face challenges reaching growth and nutritional goals. Taking pancreatic enzymes with a high calorie diet isn’t always enough to maintain a healthy weight and maximize fat and nutrient absorption.
Encala can help. It’s a mixable powder that adds healthy calories to any meal or beverage and enables your body to better absorb the fat and fat-soluble vitamins in your food.
See what Encala can do for you or your loved one »
Learn what makes Encala different »
It’s not just about eating more calories; it’s also about ensuring those calories are absorbed.
See how easy it is to use Encala »
It’s a simple, convenient way to add healthy fat to your diet.
Have Encala delivered directly to your door »
It’s fast and convenient.
Encala is a clinically proven medical food that works in two ways: First, it adds highly absorbable fat calories to meals, blended beverages, and snacks. Second, it helps your body absorb the fat and fat-soluble vitamins that are already in the food you’re eating.
A taste-neutral, gluten-free,
and non-GMO powder
made entirely from plants
Designed to mix into
your favorite foods and
blended beverages
A source of 100 healthy
calories per dose
Clinically proven to increase
overall fat absorption, weight,
and height in patients with CF
after 3 months of daily use
Supplies essential fatty acids
and choline
A medical food that meets all FDA
criteria and is intended for the
dietary management of exocrine
pancreatic insufficiency